NGLFINE

NGL Fine - Chem Share Price

₹1,313.60 +62.5 (5%)

19 May, 2025 21:10

SIP TrendupStart SIP in NGLFINE

Start SIP

Performance

  • Low
  • ₹1,251
  • High
  • ₹1,314
  • 52 Week Low
  • ₹957
  • 52 Week High
  • ₹2,778
  • Open Price₹1,251
  • Previous Close₹1,251
  • Volume4,564

Investment Returns

  • Over 1 Month + 26.3%
  • Over 3 Month + 33.61%
  • Over 6 Month -26%
  • Over 1 Year -43.85%
SIP Lightning

Smart Investing Starts Here Start SIP with NGL Fine - Chem for Steady Growth!

Invest Now

NGL Fine - Chem Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 24.9
  • PEG Ratio
  • -1.7
  • Market Cap Cr
  • 812
  • P/B Ratio
  • 2.9
  • Average True Range
  • 52.97
  • EPS
  • 52.8
  • Dividend Yield
  • 0.1
  • MACD Signal
  • 3.2
  • RSI
  • 70.78
  • MFI
  • 79.02

NGL Fine - Chem Financials

NGL Fine - Chem Technicals

EMA & SMA

Current Price
₹1,313.60
+ 62.5 (5%)
pointer
  • stock-down_img
  • Bearish Moving Average 5
  • stock-up_img
  • Bullish Moving Average 11
  • 20 Day
  • ₹1,148.04
  • 50 Day
  • ₹1,178.05
  • 100 Day
  • ₹1,335.98
  • 200 Day
  • ₹1,580.28

Resistance and Support

1292.77 Pivot Speed
  • R3 1,396.93
  • R2 1,355.27
  • R1 1,334.43
  • S1 1,271.93
  • S2 1,230.27
  • S3 1,209.43

What's your outlook on NGL Fine - Chem?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

NGL Fine-Chem Ltd. manufactures pharmaceutical intermediates and active pharmaceutical ingredients (APIs), primarily serving the veterinary, pharmaceutical, and cosmetic industries. It supplies high-quality products to domestic and international markets, focusing on reliability and innovation in chemical synthesis.

Ngl Fine-Chem has an operating revenue of Rs. 373.10 Cr. on a trailing 12-month basis. An annual revenue growth of 24% is outstanding, Pre-tax margin of 16% is great, ROE of 15% is good. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its 200DMA and around 12% up from its 50DMA. It needs to take out the 200DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 29 which is a POOR score indicating inconsistency in earnings, a RS Rating of 18 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C+ which is evident from recent supply seen, Group Rank of 93 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

NGL Fine - Chem Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-05-22 Audited Results & Final Dividend
2025-02-07 Quarterly Results
2024-11-08 Quarterly Results
2024-08-12 Quarterly Results
2024-05-21 Audited Results & Final Dividend
Date Purpose Remarks
2024-08-16 FINAL Rs.1.75 per share(35%)Final Dividend
2023-08-18 FINAL Rs.1.75 per share(35%)Final Dividend
2022-06-23 FINAL Rs.1.75 per share(35%)Final Dividend
View More

NGL Fine - Chem F&O

NGL Fine - Chem Shareholding Pattern

72.74%
0%
0%
22.75%
4.51%

About NGL Fine - Chem

  • NSE Symbol
  • NGLFINE
  • BSE Symbol
  • 524774
  • Managing Director
  • Mr. Rahul Nachane
  • ISIN
  • INE887E01022

Similar Stocks to NGL Fine - Chem

NGL Fine - Chem FAQs

NGL Fine - Chem share price is ₹1,313 As on 19 May, 2025 | 20:56

The Market Cap of NGL Fine - Chem is ₹811.5 Cr As on 19 May, 2025 | 20:56

The P/E ratio of NGL Fine - Chem is 24.9 As on 19 May, 2025 | 20:56

The PB ratio of NGL Fine - Chem is 2.9 As on 19 May, 2025 | 20:56

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23